Cortellis
Depends
Confidence: Medium
Buy if you run competitive intelligence, BD, or regulatory affairs at a pharma or biotech company with an enterprise budget.
New check
Comparison
Cortellis and DrugPatentWatch both land on Depends.
Buy if you run competitive intelligence, BD, or regulatory affairs at a pharma or biotech company with an enterprise budget.
Buy only if you run portfolio, BD, or litigation strategy inside a pharma company and need patent-cliff forecasting; the free trial makes testing cheap.
| Compare | Cortellis | DrugPatentWatch |
|---|---|---|
| Verdict | Depends | Depends |
| Best for | Big pharma competitive intelligence teams | Pharma portfolio and lifecycle strategy teams |
| Who it's not for | Small biotech startups . pricing will swallow your budget | Hospitals, clinics, pharmacies . clinical needs, not market intelligence |
| Privacy | No known public vulnerabilities found in the sources reviewed.⁷ | No known public vulnerabilities found in the sources reviewed.12 |
| Support quality | No usable evidence found | No support evidence in sources |
| Public sentiment | Reddit users acknowledge the data power but repeatedly question the cost relative to smaller organizations' needs.² | No independent user reviews surfaced in the sources reviewed; coverage is vendor-authored content and trade news.15 |
| Biggest gotcha | Guess: annual contracts likely run five figures; no public list price to benchmark² | Expect an enterprise-style sales process; published pricing is absent, so budget negotiation time.11 |